Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Greene

Showing results (81-90 of 219) with videos related to

Pageof 22
Sort By:
International Journal of Cancer|September 21, 2011
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenomaYing Gao, Hormuzd Katki, Barry Graubard, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 22, 2016
Research participant interest in primary, secondary, and incidental genomic findingsJennifer T Loud, Renee C Bremer, Phuong L Mai, et al.
Journal of the National Cancer Institute|May 13, 2011
Confirmation of family cancer history reported in a population-based surveyPhuong L Mai, Anne O Garceau, Barry I Graubard, et al.
Journal of Medical Genetics|May 28, 2011
Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumourChristian P Kratz, Summer S Han, Philip S Rosenberg, et al.
International Journal of Cancer|November 9, 2017
Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research DatalinkYoujin Wang, Ruth M Pfeiffer, Rotana Alsaggaf, et al.
BMC Genetics|October 6, 2007
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studiesLutécia H Mateus Pereira, Marbin A Pineda, William H Rowe, et al.
International Journal of Molecular Epidemiology and Genetics|December 15, 2010
Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention TrialBarbara K Dunn, Mark H Greene, Jenny M Kelley, et al.
Frontiers in Neurology|November 5, 2019
Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM RegistriesCecilia Higgs, James E Hilbert, Libby Wood, et al.
Hereditary Cancer in Clinical Practice|February 25, 2014
Familial testicular germ cell tumor: no associated syndromic pattern identifiedChristine M Mueller, Larissa A Korde, Mary L McMaster, et al.
Human Reproduction (Oxford, England)|April 5, 2018
Subphenotype meta-analysis of testicular cancer genome-wide association study data suggests a role for RBFOX family genes in cryptorchidism susceptibilityYanping Wang, Dione R Gray, Alan K Robbins, et al.
Pageof 22

Showing results (81-90 of 219) with videos related to

Sort By:
Pageof 22
International Journal of Cancer|September 21, 2011
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenomaYing Gao, Hormuzd Katki, Barry Graubard, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 22, 2016
Research participant interest in primary, secondary, and incidental genomic findingsJennifer T Loud, Renee C Bremer, Phuong L Mai, et al.
Journal of the National Cancer Institute|May 13, 2011
Confirmation of family cancer history reported in a population-based surveyPhuong L Mai, Anne O Garceau, Barry I Graubard, et al.
Journal of Medical Genetics|May 28, 2011
Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumourChristian P Kratz, Summer S Han, Philip S Rosenberg, et al.
International Journal of Cancer|November 9, 2017
Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research DatalinkYoujin Wang, Ruth M Pfeiffer, Rotana Alsaggaf, et al.
BMC Genetics|October 6, 2007
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studiesLutécia H Mateus Pereira, Marbin A Pineda, William H Rowe, et al.
International Journal of Molecular Epidemiology and Genetics|December 15, 2010
Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention TrialBarbara K Dunn, Mark H Greene, Jenny M Kelley, et al.
Frontiers in Neurology|November 5, 2019
Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM RegistriesCecilia Higgs, James E Hilbert, Libby Wood, et al.
Hereditary Cancer in Clinical Practice|February 25, 2014
Familial testicular germ cell tumor: no associated syndromic pattern identifiedChristine M Mueller, Larissa A Korde, Mary L McMaster, et al.
Human Reproduction (Oxford, England)|April 5, 2018
Subphenotype meta-analysis of testicular cancer genome-wide association study data suggests a role for RBFOX family genes in cryptorchidism susceptibilityYanping Wang, Dione R Gray, Alan K Robbins, et al.
Pageof 22